Investor
LSX World Congress
A high-level life science partnering and investment event connecting biotech, medtech, and healthtech executives with global investors.
- When
- April, Late April
- Where
- London, United KingdomView on Google Maps
- Format
- In person
- Organiser
- LSX Ltd
- Region
- Europe
- Scale
- About 1,500 attendees
- Founded
- 2015
The Signal
LSX World Congress is a focused investment and partnering conference for the life sciences sector, held annually in London. Organized by LSX Ltd, the event concentrates on connecting chief executives of biotech, medtech, and digital health firms with capital. The format relies heavily on pre-scheduled, one-to-one partnering meetings alongside strategic panel discussions on corporate development. For healthtech and life sciences operators, it is a key event for raising late-stage capital and exploring pharmaceutical licensing deals.
What to expect
- Announcements of cross-border venture capital funding rounds
- Biotech and medtech licensing agreements with large pharmaceutical firms
- Panel discussions on global life science investment climates
- Strategic corporate presentations from growth-stage companies
Who is in the room
Attendees include life science chief executives, venture capital partners, private equity directors, pharmaceutical licensing executives, and industry advisors.
Background
LSX World Congress was created to address the gap in high-quality executive networks and capital access in Europe's life sciences sector. It has grown into a major international hub for pharmaceutical and medtech dealmaking.
Related events
Running this event, or spotted something out of date?